# Nuclide record cellbion (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/cellbion/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "cellbion" ;
  schema:name "CellBion"@en ;
  schema:alternateName "CellBion Co., Ltd."@en, "Cellbion"@en ;
  schema:description "A Korean company developing a lutetium-177 prostate cancer therapy of its own, now filed for conditional approval in Korea."@en ;
  schema:url <https://nuclide.cc/companies/cellbion/>, <http://cellbion.co.kr/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <http://cellbion.co.kr/?r=reen&c=98/105>, <http://cellbion.co.kr/?r=reen&c=99/108> ;
  schema:addressCountry "KR" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/>, <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/institutions/ksnm/>, <https://nuclide.cc/institutions/kirams/>, <https://nuclide.cc/isotopes/ga-68/> .